Bench to bedside review of myositis autoantibodies | Clinical and Molecular Allergy | Full Text
Rheumatologic Tests: A Primer for Family Physicians | AAFP
UPDATES IN ANTIBODY TESTING IN RHEUMATOLOGY - ppt video online download
Life | Free Full-Text | Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies
Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
StudyXing Medicine on X: "Polymyositis: Autoimmune, inflammatory muscle destruction --> proximal bilateral wkness (shoulders, hips MC), fatigue, inability to rise from sitting; Pos+ anti-Jo-1, anti-SRP, anti-Mi-2 antibodies, high CK; Bx: endomysial ...
Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
Frequency of anti-Jo-1 and smoking status by country | Download Table
Anti-OJ autoantibodies: Rare or underdetected? - ScienceDirect
How to Diagnose Antisynthetase Syndrome - Page 3 of 5 - The Rheumatologist
What does it mean if a patient is positive for... | F1000Research
SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X
SciELO - Brasil - Síndrome antissintetase anti-Jo-1 Síndrome antissintetase anti-Jo-1
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports
Barone Mnemonic: Dermatomyositis
Anti-Synthetase (Anti-Jo-1) Autoantibodies - YouTube
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies | BMC Pulmonary Medicine | Full Text
AC Anti JO-1 - Laboratorio Médico Samalab
Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports
Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | Semantic Scholar
Anti-Jo1 autoantibodies, from clinic to the bench | Rheumatology & Autoimmunity
Main Characteristics of Anti Jo-1 Patients at Disease Onset According... | Download Table
Antisynthetase Syndrome (AS) - Myositis Support and Understanding
